Millipore Sigma Vibrant Logo

CC12 Anti-Cyclin D1 (Ab-3) Mouse mAb (DCS-6)

CC12
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

Species ReactivityHostAntibody Type
H, M, R M Monoclonal Antibody

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
CC12-100UGCN
Retrieving availability...
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      塑膠安瓿;塑膠針藥瓶 100 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewRecognizes cyclin D1 in MCF-7 and A431 cells. Does not react with cyclins D2 and D3.
      Catalogue NumberCC12
      Brand Family Calbiochem®
      SynonymsAnti-Bcl-1, Anti-PRAD-1
      References
      ReferencesInaba, T., et al. 1992. Genomics 13, 565.
      Jiang, W., et al. 1992. Cancer Res. 2, 2980.
      Pines, J. 1992. Cell Growth Differ. 2, 305.
      Xiong, Y., et al. 1992. Genomics 13, 575.
      Xiong, Y., et al. 1992. Cell 71, 504.
      Motokura, T., et al. 1991. Nature 350, 512.
      Solomon, M.J., et al. 1990. Cell 63, 1013.
      Draetta, G., and Beach, D. 1988. Cell 54, 17.
      Product Information
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin.
      Negative controltrp E (Ab-1)
      Positive controlMCF7, or A431 cells or breast carcinoma tissue
      Preservative≤0.1% sodium azide
      Quality LevelMQ100
      Applications
      Application ReferencesImmunoblotting, Immunoprecipitation, and Neutralization Studies Lukas, J., et al. 1994. Oncogene 9, 707. Immunofluorescence and Flow Cytometry Bartkova, J., et al. 1995. Cancer Res. 55, 949-956. Bartkova, J., et al. 1994. J. Pathol. 172, 237-245. Lukas, J., et al. 1994. Oncogene 9, 707. Paraffin and Frozen Sections Bartkova, J., et al. 1995. Cancer Res. 55, 949-956. Bartkova, J., et al. 1994. J. Pathol. 172, 237-245. Gillett, C., et al. 1994. Cancer Res. 54, 1812-1817.
      Key Applications Immunofluorescence
      Immunoprecipitation
      Neutralization Studies
      Paraffin Sections
      Flow Cytometry
      Frozen Sections
      Immunoblotting (Western Blotting)
      Application NotesFlow Cytometry (5 µg/ml; Cat. No. CC12, CC12F)
      Frozen Sections (see application references)
      Immunoblotting (1 µg/ml)
      Immunofluorescence (5 µg/ml; Cat. No. CC12, CC12F)
      Immunoprecipitation (see application references)
      Neutralization Studies (see application references)
      Paraffin Sections (5 µg/ml, heat pre-treatment required)
      Application CommentsDoes not react with cyclins D2 or D3. Staining of paraffin sections can also be detected with pepsin or trypsin pretreatment; light staining will be detected without pretreatment. Do not microwave sections, as this may destroy staining. For immunofluorescence and flow cytometry, we recommend using the FITC conjugate (Cat. No. CC12F). Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenrecombinant human cyclin D1
      ImmunogenHuman
      CloneDCS-6
      HostMouse
      IsotypeIgG2a
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Anti-Cyclin D1 (Ab-3) Mouse mAb (DCS-6) Certificates of Analysis

      TitleLot Number
      CC12

      References

      Reference overview
      Inaba, T., et al. 1992. Genomics 13, 565.
      Jiang, W., et al. 1992. Cancer Res. 2, 2980.
      Pines, J. 1992. Cell Growth Differ. 2, 305.
      Xiong, Y., et al. 1992. Genomics 13, 575.
      Xiong, Y., et al. 1992. Cell 71, 504.
      Motokura, T., et al. 1991. Nature 350, 512.
      Solomon, M.J., et al. 1990. Cell 63, 1013.
      Draetta, G., and Beach, D. 1988. Cell 54, 17.

      Citations

      Title
    • Takeshi Shimamura, et al. (2005) Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Research 65, 6401-6408.
    • Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision01-August-2007 RFH
      SynonymsAnti-Bcl-1, Anti-PRAD-1
      ApplicationFlow Cytometry (5 µg/ml; Cat. No. CC12, CC12F)
      Frozen Sections (see application references)
      Immunoblotting (1 µg/ml)
      Immunofluorescence (5 µg/ml; Cat. No. CC12, CC12F)
      Immunoprecipitation (see application references)
      Neutralization Studies (see application references)
      Paraffin Sections (5 µg/ml, heat pre-treatment required)
      DescriptionPurified mouse monoclonal antibody generated by immunizing mice with the specified immunogen and fusing splenocytes with NS/1 mouse myeloma cells. Recognizes the cyclin D1 protein.
      BackgroundCyclins are a family of proteins implicated in the induction and control of mitosis. They are characterized by their accumulation and dramatic destruction in a cell cycle dependent manner. Cyclins are necessary for cdc/cdk kinase activity and are one of the subunits of the active kinase, in association with cdc2 or one of the cdk family members. Several different major cyclin families have been identified to date. These include the A, B, D and E family of cyclins. The D family of cyclins has been associated with a wide variety of proliferative diseases but their biochemical role is still unknown. The D cyclins appear in early G1, before the B cyclins. The human cyclin D1 gene has been mapped to the 11q13 locus and has been shown to be the PRAD1 gene product. PRAD1 was originally identified as being a clonally rearranged and overexpressed gene linked to the bcl-1 locus in a subset of benign parathyroid tumors. Amplification of cyclin D1 genes has also been demonstrated in human esophageal cancer.
      HostMouse
      Immunogen speciesHuman
      Immunogenrecombinant human cyclin D1
      CloneDCS-6
      IsotypeIgG2a
      Specieshuman, mouse, rat
      Positive controlMCF7, or A431 cells or breast carcinoma tissue
      Negative controltrp E (Ab-1)
      FormLiquid
      FormulationIn 50 mM sodium phosphate buffer, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsDoes not react with cyclins D2 or D3. Staining of paraffin sections can also be detected with pepsin or trypsin pretreatment; light staining will be detected without pretreatment. Do not microwave sections, as this may destroy staining. For immunofluorescence and flow cytometry, we recommend using the FITC conjugate (Cat. No. CC12F). Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesInaba, T., et al. 1992. Genomics 13, 565.
      Jiang, W., et al. 1992. Cancer Res. 2, 2980.
      Pines, J. 1992. Cell Growth Differ. 2, 305.
      Xiong, Y., et al. 1992. Genomics 13, 575.
      Xiong, Y., et al. 1992. Cell 71, 504.
      Motokura, T., et al. 1991. Nature 350, 512.
      Solomon, M.J., et al. 1990. Cell 63, 1013.
      Draetta, G., and Beach, D. 1988. Cell 54, 17.
      Citation
    • Takeshi Shimamura, et al. (2005) Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Research 65, 6401-6408.
    • Application referencesImmunoblotting, Immunoprecipitation, and Neutralization Studies Lukas, J., et al. 1994. Oncogene 9, 707. Immunofluorescence and Flow Cytometry Bartkova, J., et al. 1995. Cancer Res. 55, 949-956. Bartkova, J., et al. 1994. J. Pathol. 172, 237-245. Lukas, J., et al. 1994. Oncogene 9, 707. Paraffin and Frozen Sections Bartkova, J., et al. 1995. Cancer Res. 55, 949-956. Bartkova, J., et al. 1994. J. Pathol. 172, 237-245. Gillett, C., et al. 1994. Cancer Res. 54, 1812-1817.